Wednesday, October 23, 2019

Strides Pharma gets USFDA inspection report for Alathur unit with no adverse observations

Strides Pharma gets USFDA inspection report for Alathur unit with no adverse observations It has received the establishment inspection report (EIR), thereby confirming the successful closure of the inspections, the company added.

from Moneycontrol Business News https://ift.tt/360iCHe

No comments:

Post a Comment

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...